Adaptimmune Therapeutics PLC (ADAPY) › Total AssetsAdaptimmune Therapeutics PLC (ADAPY) — Total AssetsAnnual figures by fiscal year, from SEC filings.2015: $285.82M2016: $234.51M2017: $281.15M2018: $276.74M2019: $181.54M2020: $451.14M2021: $469.55M2022: $328.92M2023: $282.62M2024: $245.96M$245.96M2015Total Assets (USD)2024Fiscal YearTotal AssetsChange YoY2024$245.96M-13.0%2023$282.62M-14.1%2022$328.92M-30.0%2021$469.55M+4.1%2020$451.14M+148.5%2019$181.54M-34.4%2018$276.74M-1.6%2017$281.15M+19.9%2016$234.51M-18.0%2015$285.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share